[HTML][HTML] Advancing therapeutic strategies for Epstein-Barr virus-associated malignancies through lytic reactivation
H Tan, Y Gong, Y Liu, J Long, Q Luo, OD Faleti… - Biomedicine & …, 2023 - Elsevier
Epstein-Barr virus (EBV) is a widespread human herpes virus associated with lymphomas
and epithelial cell cancers. It establishes two separate infection phases, latent and lytic, in …
and epithelial cell cancers. It establishes two separate infection phases, latent and lytic, in …
Advances in Intralesional Therapy for Locoregionally Advanced and Metastatic Melanoma: Five Years of Progress
DK DePalo, JS Zager - Cancers, 2023 - mdpi.com
Simple Summary The prognosis for patients with locoregionally advanced and metastatic
melanoma remains poor despite advances in systemic therapy. By delivering therapeutics …
melanoma remains poor despite advances in systemic therapy. By delivering therapeutics …
The expression and function of HSV ICP47 and its promoter in mice
T Velusamy, N Singh, S Croft, S Smith… - Journal of …, 2023 - Am Soc Microbiol
Herpes simplex virus (HSV) protein immediate early-infected cell protein (ICP) 47 inhibits
the transporter associated with antigen presentation, thereby concealing infected cells from …
the transporter associated with antigen presentation, thereby concealing infected cells from …
Varicella Zoster Virus Impairs Expression of the Nonclassical Major Histocompatibility Complex Class I–Related Gene Protein (MR1)
SK Purohit, C Samer, HEG McWilliam… - The Journal of …, 2023 - academic.oup.com
The antigen presentation molecule MR1 (major histocompatibility complex, class I–related)
presents ligands derived from the riboflavin (vitamin B) synthesis pathway, which is not …
presents ligands derived from the riboflavin (vitamin B) synthesis pathway, which is not …
Neoadjuvant use of oncolytic herpes virus G47Δ prevents local recurrence after insufficient resection in tongue cancer models
K Inoue, H Ito, M Iwai, M Tanaka, Y Mori… - Molecular Therapy …, 2023 - cell.com
A complete resection of tongue cancer is often difficult. We investigate the usefulness of
administering G47Δ (teserpaturev), a triple-mutated oncolytic herpes simplex virus type 1 …
administering G47Δ (teserpaturev), a triple-mutated oncolytic herpes simplex virus type 1 …
The Quest for Immunity: Exploring Human Herpesviruses as Vaccine Vectors
Herpesviruses are large DNA viruses that have long been used as powerful gene therapy
tools. In recent years, the ability of herpesviruses to stimulate both innate and adaptive …
tools. In recent years, the ability of herpesviruses to stimulate both innate and adaptive …
Fusion peptide is superior to co-expressing subunits for arming oncolytic herpes virus with interleukin 12
H Fukuhara, YT Sato, J Hou, M Iwai… - Communications Medicine, 2023 - nature.com
Background G47∆ is a triple-mutated oncolytic herpes simplex virus type 1 (HSV-1) recently
approved as a new drug for malignant glioma in Japan. As the next-generation, we develop …
approved as a new drug for malignant glioma in Japan. As the next-generation, we develop …
Genetic engineering of animal DNA viruses in order to study and modify pathogenesis
DA Leib - Genetically Engineered Viruses, 2023 - taylorfrancis.com
Amongst the DNA viruses, the herpesvirus family has been perhaps the most extensively
studied in terms of genetics and pathogenesis, and will therefore be the primary focus for …
studied in terms of genetics and pathogenesis, and will therefore be the primary focus for …